Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2025-12-28 @ 8:14 PM
Study NCT ID:
NCT03496766
Status:
TERMINATED
Last Update Posted:
2025-03-05
First Post:
2018-03-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Tipifarnib in Advanced Squamous NSCLC With Oncogen HRAS MutAtionS
Sponsor:
Spanish Lung Cancer Group
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GECP17/04_THOMAS
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None